AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 receptor agonists. If you are asking what is semaglutide, it is a prescription ...

Hollow graphene aerogel fibers mimicking polar bear hair achieve record-low thermal conductivity and high electrical ...

Find the healthiest lunch meats by comparing sodium, saturated fat, and preservatives. Learn which cold cuts are better for your sandwiches.

This study presents valuable findings implicating nuclear export in the regulation of protein condensate behaviour and TDP-43 phase behaviour, suggesting a link to pathogenic aggregation in ALS/FTD.

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year ...

Orforglipron carried more side effects, however ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational ...

© 2026 Forbes Media LLC. All Rights Reserved.

Forget the vitamin gummy. Mobile IV therapy has moved well beyond hangovers, and a booming longevity industry is fueling its next chapter.

DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on March 9thDESMODA eliminates tablet splitting and crushing, enabling precise, individualized dosing ...

Q4 2025 revenues of $112M, +46% vs. Q4 2024Furoscix® Q4 2025 net sales of $23M, +91% vs. Q4 2024 Afrezza® Q4 2025 net sales of $23M, +25% vs. Q4 ...

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...